Steve Carlos

Steve Carlos brings more than 25 years of experience in pharmaceutical and biological manufacturing in biologics, small molecule, and medical devices. Prior to joining Ashvattha, Steve served as Senior Director of Manufacturing/CMC at Takeda Pharmaceuticals (formerly Maverick Pharmaceuticals), where he directed CMC and manufacturing activities for drug substances and drug products (biologics) on four drug development programs (conditionally activated bispecific recombinant proteins). Prior to Takeda, Steve was Director of Clinical Manufacturing at Novartis, where he was responsible for the manufacture of numerous Novartis and partner clinical programs (inhalation and oral) and supported multiple regulatory filings. He also held senior positions in Manufacturing/CMC at other life science companies, including Portola Pharmaceuticals, MAP Pharmaceuticals (acquired by Allergan), and Europharma. Steve holds a BSc in Microbiology, Biochemistry, and Chemistry from the University of Victoria, Canada.